English | Español

Regulatory
+ Regulatory
John Breslin | Jul 27, 2017

States urged to embrace telemedicine by study author
+ Regulatory
Nicholas Gueguen | Jul 27, 2017

Coping strategies can cut opioid use after surgery, study finds
+ Regulatory
Nicholas Gueguen | Jul 27, 2017

Puma Biotechnology lines up participants for Phase III breast cancer test
+ Regulatory
Nicholas Gueguen | Jul 26, 2017

Bullying by medical professionals reduces quality of care, study finds
+ Regulatory
Nicholas Gueguen | Jul 23, 2017

FDA approves AstraZeneca's Tagrisso for treating certain forms of lung cancer
+ Regulatory
Nicholas Gueguen | Jul 23, 2017

Novartis says its Entresto better than enalapril in managing blood sugar levels of diabetics who had heart failure
+ Regulatory
Nicholas Gueguen | Jul 23, 2017

GlaxoSmithKline study to test mepolizumab for fighting severe hypereosinophilic syndrome
+ Regulatory
Nicholas Gueguen | Jul 20, 2017

Aetna may leave Illinois Medicaid program unless state pays up

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes